BC-3781 Study Center 012 — Columbus, Georgia

BC-3781 Study Center 012 is a clinical research site located in Columbus, Georgia, United States 31904.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

BC-3781 Study Center 012 has participated in 1 clinical trials.

Therapeutic areas: Bacterial Infections, Infection.

Sponsors: Nabriva Therapeutics AG.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for BC-3781 Study Center 012?

BC-3781 Study Center 012 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has BC-3781 Study Center 012 conducted?

BC-3781 Study Center 012 has 1 clinical trials on record. Their work covers Bacterial Infections, Infection.

Is BC-3781 Study Center 012 accredited by Crixeo Health?

BC-3781 Study Center 012 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about BC-3781 Study Center 012?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.